An updated review of lipid‐modifying therapy
LA Simons - Medical Journal of Australia, 2019 - Wiley Online Library
Statin drugs reduce low‐density lipoprotein (LDL)‐cholesterol (LDL‐C) and cardiovascular
risk. Ezetimibe may be used to supplement statin therapy, or used alone in cases of statin …
risk. Ezetimibe may be used to supplement statin therapy, or used alone in cases of statin …
An updated review of lipid‐modifying therapy
LA Simons - The Medical Journal of Australia, 2019 - mja.com.au
Statin drugs reduce low‐density lipoprotein (LDL)‐cholesterol (LDL‐C) and cardiovascular
risk. Ezetimibe may be used to supplement statin therapy, or used alone in cases of statin …
risk. Ezetimibe may be used to supplement statin therapy, or used alone in cases of statin …
An updated review of lipid-modifying therapy
LA Simons - The Medical journal of Australia, 2019 - pubmed.ncbi.nlm.nih.gov
Statin drugs reduce low-density lipoprotein (LDL)-cholesterol (LDL-C) and cardiovascular
risk. Ezetimibe may be used to supplement statin therapy, or used alone in cases of statin …
risk. Ezetimibe may be used to supplement statin therapy, or used alone in cases of statin …
An updated review of lipid-modifying therapy.
LA Simons - The Medical Journal of Australia, 2019 - europepmc.org
Statin drugs reduce low-density lipoprotein (LDL)-cholesterol (LDL-C) and cardiovascular
risk. Ezetimibe may be used to supplement statin therapy, or used alone in cases of statin …
risk. Ezetimibe may be used to supplement statin therapy, or used alone in cases of statin …